Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Wet Macular Degeneration”

381 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 381 results

Not applicableStudy completedNCT03438669
What this trial is testing

Correlation Between Visual Acuity Measurements, Quality of Life and Morphological Parameters in Wet AMD Patients

Who this might be right for
Macular Degeneration
Dr. med. Katja Hatz 53
Large-scale testing (Phase 3)Study completedNCT00590694
What this trial is testing

Lucentis for Age-related Macular Degeneration Pigment Epithelial Detachments

Who this might be right for
Age-related Macular DegenerationPigment Epithelial DetachmentNeovascular Macular Degeneration+1 more
Pacific Eye Associates 15
Not applicableStudy completedNCT03470103
What this trial is testing

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

Who this might be right for
Macular Degeneration
Bayer 643
Not applicableActive Not RecruitingNCT04645212
What this trial is testing

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Who this might be right for
Wet Age-related Macular DegenerationNeovascular Age-related Macular Degeneration
Adverum Biotechnologies, Inc. 23
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Testing effectiveness (Phase 2)Ended earlyNCT02418754
What this trial is testing

Study of Intravitreal REGN2176-3 in Participants With Neovascular ("Wet") Age-Related Macular Degeneration (AMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Regeneron Pharmaceuticals 505
Testing effectiveness (Phase 2)Study completedNCT05637255
What this trial is testing

A Randomized, Double Masked, Parallel Group, Dose-finding Study to Evaluate SYL1801 in Patients With Neovascular Age-related Macular Degeneration (AMD)

Who this might be right for
Wet Macular DegenerationNeovascular Age-related Macular DegenerationMacular Degeneration
Sylentis, S.A. 99
Early research (Phase 1)UnknownNCT03675880
What this trial is testing

TAB014(Drug Code) in Wet( Neovascular)Age-related Macular Degeneration(AMD) Subjects

Who this might be right for
AMD
Lee's Pharmaceutical Limited 24
Not applicableStudy completedNCT05324150
What this trial is testing

M Charts Versus Amsler Test in Evaluating Metamorphopsia in nAMD

Who this might be right for
Macular Degeneration, WetMetamorphopsia
Ospedale Santa Croce-Carle Cuneo 57
Not applicableUnknownNCT00403026
What this trial is testing

Intravitreal Bevacizumab for Retinal Disorders

Who this might be right for
Wet AMDMacular OedemaProliferative Diabetic Retinopathy
Narayana Nethralaya 150
Not applicableLooking for participantsNCT06718816
What this trial is testing

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 21
Early research (Phase 1)Study completedNCT02461771
What this trial is testing

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD

Who this might be right for
Neovascular Age-Related Macular Degeneration
Apellis Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT03869684
What this trial is testing

Assess the Safety, Tolerability and Effectiveness of MT-0814 for the Treatment of Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Senju Pharmaceutical Co., Ltd. 13
Testing effectiveness (Phase 2)Ended earlyNCT01189019
What this trial is testing

HiPED - High Dose Lucentis for Persistent Pigment Epithelial Detachments in Age-related Macular Degeneration

Who this might be right for
Wet Macular DegenerationMacular DegenerationRetinal Pigment Epithelial Detachment
Anne Fung MD 40
Early research (Phase 1)Study completedNCT02543229
What this trial is testing

Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD

Who this might be right for
Eye DiseasesMacular DegenerationRetinal Diseases+2 more
Opthea Limited 51
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Post-approval studies (Phase 4)Study completedNCT01617148
What this trial is testing

Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept

Who this might be right for
Exudative Macular Degeneration
Rishi Singh 26
Early research (Phase 1)Study completedNCT03249740
What this trial is testing

A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Neovascular (Wet) Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Graybug Vision 32
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Next Page